We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$905M
AUM Growth
-$6.65M
Cap. Flow
+$9.3M
Cap. Flow %
1.03%
Top 10 Hldgs %
52.46%
Holding
657
New
198
Increased
119
Reduced
86
Closed
223

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$67.4M
2
PFE icon
Pfizer
PFE
+$65.6M
3
APTV icon
Aptiv
APTV
+$29.7M
4
MRNA icon
Moderna
MRNA
+$22.6M
5
CRM icon
Salesforce
CRM
+$19.6M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$85.2M
2
RUN icon
Sunrun
RUN
+$64.1M
3
TPIC
TPI Composites
TPIC
+$31.4M
4
MSFT icon
Microsoft
MSFT
+$30.9M
5
AMZN icon
Amazon
AMZN
+$30.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.6%
2 Healthcare 14.17%
3 Technology 11.37%
4 Financials 4.47%
5 Communication Services 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WSR
426
DELISTED
Whitestone REIT
WSR
$103K 0.01%
+10,565
New +$96.8K
QTTB icon
427
Q32 Bio
QTTB
$466M
$103K 0.01%
+729
New +$92.9K
XLI icon
428
State Street Industrial Select Sector SPDR ETF
XLI
$34.5B
$98K 0.01%
+1,000
New +$103K
CMCM
429
Cheetah Mobile
CMCM
$98.1M
$71K 0.01%
8,751
-1,180
-12% -$11.6K
UXIN
430
Uxin Ltd
UXIN
$257M
$67K 0.01%
+244
New +$80.6K
KRMD icon
431
KORU Medical Systems
KRMD
$157M
$59K 0.01%
20,798
– –
OVID icon
432
Ovid Therapeutics
OVID
$489M
$58K 0.01%
17,386
– –
NPKI
433
NPK International
NPKI
$1.15B
$48K 0.01%
+14,522
New +$41K
CCO icon
434
Clear Channel Outdoor Holdings
CCO
$1.23B
$29K ﹤0.01%
10,614
-2,478
-19% -$6.19K
AAON icon
435
Aaon
AAON
$7.31B
– –
-10,373
Closed -$433K
ADM icon
436
Archer Daniels Midland
ADM
$38.8B
– –
-4,008
Closed -$243K
AGYS icon
437
Agilysys
AGYS
$3.02B
– –
-3,825
Closed -$218K
AMC icon
438
PUT
AMC Entertainment Holdings
AMC
$2.16B
– –
-500
Closed -$283K
AME icon
439
Ametek
AME
$58B
– –
-2,055
Closed -$274K
APAM icon
440
Artisan Partners
APAM
$3B
– –
-15,094
Closed -$767K
APD icon
441
Air Products & Chemicals
APD
$68.6B
– –
-1,602
Closed -$461K
APLE icon
442
Apple Hospitality REIT
APLE
$3.71B
– –
-19,320
Closed -$295K
APO icon
443
Apollo Global Management
APO
$76B
– –
-11,158
Closed -$694K
ARES icon
444
Ares Management
ARES
$31B
– –
-9,751
Closed -$620K
ARKK icon
445
ARK Innovation ETF
ARKK
$6.37B
– –
-20,000
Closed -$2.62M
EFOR
446
Everforth Inc
EFOR
$1.33B
– –
-7,375
Closed -$715K
ATOM icon
447
Atomera
ATOM
$210M
– –
-9,980
Closed -$214K
AVAV icon
448
AeroVironment
AVAV
$9.57B
– –
-4,734
Closed -$474K
AVY icon
449
Avery Dennison
AVY
$13.5B
– –
-1,186
Closed -$249K
AYI icon
450
Acuity Brands
AYI
$10.6B
– –
-1,745
Closed -$326K
16 17
18
19 20

Similar funds

BFM
Boston Financial Management Boston, Massachusetts $3.31B AUM 19.4% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
KL
KGH Ltd Nassau, Bahamas $1.92B AUM 13.96% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
RDIA
RE Dickinson Investment Advisors Council Bluffs, Iowa $1.77B AUM 15.45% 1-Year Est. Return

Caxton Associates (New York)'s Q3 2021 Portfolio in Review

As of Q3 2021, Caxton Associates (New York) held 657 positions worth $905M, down 0.73% from $912M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Caxton Associates (New York)'s Q3 2021 filing shows 198 new, 119 increased, 86 reduced and 223 closed positions. Its largest new stake was Pfizer: 1,480,000 shares worth $63.7M. The largest sale was Baidu, an estimated $85.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

  • Caxton Associates (New York)'s largest Q3 2021 buy was Pfizer: 1,480,000 shares worth $63.7M.
  • Caxton Associates (New York) added most to Tesla in Q3 2021, an estimated $67.4M increase.
  • Caxton Associates (New York)'s biggest Q3 2021 reduction was Sunrun, cutting an estimated $64.1M.
  • Caxton Associates (New York) fully exited Baidu in Q3 2021, selling an estimated $85.2M.
  • Caxton Associates (New York)'s ten largest holdings make up 52% of its $905M portfolio in Q3 2021.
  • Caxton Associates (New York) opened 198 new positions and closed 223 in Q3 2021.
  • Caxton Associates (New York)'s portfolio value fell 0.73% quarter-over-quarter to $905M.

Based on Caxton Associates (New York)'s 13F filing for Q3 2021, filed 15 Nov 2021.